New test aims to spot kidney cancer early with just a blood or urine sample
NCT ID NCT02664883
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood and urine test to see if it can find kidney cancer early and track how well treatment is working. Researchers will compare test results from healthy people, patients with early-stage kidney cancer, and patients with advanced kidney cancer. The goal is to develop a simple, non-invasive way to detect and monitor the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive antibody hunt: could a new scan outsmart hidden kidney cancer?
- Can a special MRI spot kidney cancer better?
- Brain mapping study probes how we sense and move
- Can MRI and tissue tests predict breast cancer before it starts?
- New drug cocktail shows promise against Hard-to-Treat cancers
- Scientists seek immune system clues from cancer patients and healthy volunteers